GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹32 Cr | ₹3.58 Cr | ₹1.90 Cr | ₹2.02 Cr | ₹2.50 Cr |
What is the latest Total Non-Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹3.58 Cr |
| Mar2023 | ₹1.90 Cr |
| Mar2022 | ₹2.02 Cr |
| Mar2021 | ₹2.50 Cr |
How is Total Non-Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 804.72 | |
| Mar2024 | ₹3.58 Cr | 87.92 | |
| Mar2023 | ₹1.90 Cr | -5.84 | |
| Mar2022 | ₹2.02 Cr | -18.96 | |
| Mar2021 | ₹2.50 Cr | - | |
Compare Total Non-Current Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,023.7 Cr | -7.3% | -13.2% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -7.3% |
-13.2% |
14% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses